Peptech

Peptech Limited focuses on the research and development of peptides and proteins in the areas of human pharmaceuticals and animal health. Peptech holds a 36.1 per cent shareholding in Domantis, a UK-based drug development company, and has formed a 50/50 joint venture company with Biosceptre. The company is positioned to become a globally recognised leader in biopharmaceutical development. For more information, please visit www.peptech.com. 
 

News

Peptech ASX: PTD - Shareholders Approve Peptech-Evogenix Merger - Dr John Chiplin, CEO

🕔8/9/2007 2:17:00 PM 7893

Peptech (ASX: PTD) - Shareholders Approve Peptech-Evogenix Merger - Dr John Chiplin, CEO; Peptech (ASX: PTD) present the following audio webcast regarding "Shareholders Approve Peptech-Evogenix Merger". You may also download this audio webcast to your computer or portable audio player.

Read Full Article

Peptech ASX: PTD - Peptech Presentation To Eg Capital Forum - Dr John Chiplin, CEO

🕔7/12/2007 11:45:00 AM 8763

Peptech (ASX: PTD) - Peptech presentation to eG Capital Forum - Dr John Chiplin, CEO; Peptech (ASX: PTD) present the following audio webcast regarding "Peptech presentation to eG Capital Forum".

Read Full Article

Peptech ASX: PTD - Merger Roadshow Presentation - Dr John Chiplin, MD; Dr Phil Jennings, Exec. Director and Dr Cliff Holloway, VP of Bus. Development

🕔6/6/2007 10:49:00 AM 7709

Peptech (ASX: PTD) - Merger Roadshow Presentation - Dr John Chiplin, MD; Dr Phil Jennings, Exec.

Read Full Article

Peptech ASX: PTD - Enters Phase I Clinical Trials - Dr Phil Jennings, Executive Director

🕔5/22/2007 1:22:00 PM 6378

Peptech (ASX: PTD) - Enters Phase I Clinical Trials - Dr Phil Jennings, Executive Director; Boardroomradio is pleased to announce that Peptech (ASX: PTD) has published an audio file.

Read Full Article

Peptech ASX: PTD - Record Profit for Half Year - Dr John Chiplin, MD

🕔5/17/2007 3:55:00 PM 6188

Peptech (ASX: PTD) - Record Profit for Half Year - Dr John Chiplin, MD; Boardroomradio is pleased to announce that Peptech (ASX: PTD) has published an audio file.

Read Full Article

Peptech ASX: PTD - Peptech & EvoGenix Merge to Form Antibody Powerhouse - Dr John Chiplin and Dr Merilyn Sleigh

🕔5/7/2007 11:52:00 AM 6735

Peptech (ASX: PTD) - Peptech & EvoGenix Merge to Form Antibody Powerhouse - Dr John Chiplin and Dr Merilyn Sleigh; Boardroomradio is pleased to announce that Peptech (ASX: PTD) has published an audio file.

Read Full Article

Peptech ASX: PTD - Suprelorin Recommendation Clears Path for Sales in Europe - Dr Paul Schober, General Manager, Peptech Animal Health

🕔3/21/2007 2:25:00 PM 4279

Peptech (ASX: PTD) - Suprelorin Recommendation Clears Path for Sales in Europe - Dr Paul Schober, General Manager, Peptech Animal Health; Boardroomradio is pleased to announce that Peptech (ASX: PTD) has published an audio file.

Read Full Article

Peptech ASX: PTD - Appoints Global Financial Adviser to Examine Strategic Options - Dr John Chiplin, CEO

🕔3/14/2007 3:19:00 PM 3144

Peptech (ASX: PTD) - Appoints Global Financial Adviser to Examine Strategic Options - Dr John Chiplin, CEO; Boardroomradio is pleased to announce that Peptech (ASX: PTD) has published an audio file.

Read Full Article

Peptech ASX: PTD - Company Update - Dr Cliff Holloway, Vice President, Business Development

🕔2/9/2007 2:52:00 PM 3583

Peptech (ASX: PTD) - Company Update - Dr Cliff Holloway, Vice President, Business Development; Boardroomradio is pleased to announce that Peptech (ASX: PTD) has published an audio file.

Read Full Article

Peptech ASX: PTD - Domantis Sale and AIM Listing - Dr John Chiplin, CEO

🕔12/21/2006 8:25:00 AM 3320

Peptech (ASX: PTD) - Domantis Sale and AIM Listing - Dr John Chiplin, CEO; Boardroomradio is pleased to announce that Peptech (ASX: PTD) has published an audio file.

Read Full Article
###

5,758 COMPANY PROFILE VIEWS

  • This Page Viewed: (Last 7 Days: 20) (Last 30 Days: 94) (Since Published: 5758) 

Company Data

    Principal Sector
  • Advertising & Media 
  • Principal Industry
  • None 
  • Homepage
  • www.peptech.com